FCMI
Foresite Capital Management IV Portfolio holdings
AUM
$230M
1-Year Est. Return
64.1%
This Fund
S&P 500
1 Year Est. Return
+64.1%
AUM
$230M
AUM Growth
+$47.1M
(+26%)
Holding
7
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pharvaris
PHVS
$1.67B
| $133M | 57.73% |
4,778,581
|
|
||
2
Cytokinetics
CYTK
$7.31B
| $29.1M | 12.68% |
458,295
|
|
||
3
Lyell Immunopharma
LYEL
$465M
| $24.6M | 10.72% |
800,399
|
|
||
|
MAZE
4
Maze Therapeutics
MAZE
$2.13B
| $21.7M | 9.43% |
522,657
|
|
||
5
Relay Therapeutics
RLAY
$1.63B
| $8.46M | 3.68% |
1,000,000
|
|
||
6
Xenon Pharmaceuticals
XENE
$3.22B
| $7.17M | 3.12% |
160,000
|
|
||
7
Alector
ALEC
$215M
| $6.06M | 2.64% |
+3,887,200
|
|